Andrew Paul Mazar - Chief Scientific Officer, Director at Monopar Therapeutics

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer, Director
Stock Symbol
MNPR on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Andrew Paul Mazar since 9/19/2023

Holdings reported by Andrew Paul Mazar for Monopar Therapeutics

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 167K $56.7K $0.34 Mar 31, 2022 Indirect
Restricted Stock Units 88.8K $30.2K $0.34 Mar 31, 2022 Direct Common Stock
Common Stock 22.1K $7.53K $0.34 Mar 31, 2022 Direct

Transactions reported by Andrew Paul Mazar for Monopar Therapeutics

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.